Pharmaceutical companies are constantly aiming for shorter drug-development cycles and advances in formulation development produce significant benefits. There is an increasing need for efficient ...
Dublin, July 30, 2025 (GLOBE NEWSWIRE) -- The "Pharma Formulation Development Outsourcing Market Size and Growth Trends and Companies 2025-2033" report has been added to ResearchAndMarkets.com's ...
LEXINGTON, KY--(Marketwired - Nov 18, 2013) - Coldstream Laboratories, Inc., a provider of sterile drug product development and manufacturing services, has announced that Adrian Raiche, Ph.D. has ...
eTheRNA Manufacturing, a specialist CDMO member of the Belgian eTheRNA group, is introducing a new Lipid Nanoparticle (LNP) formulation development and production service to support the discovery and ...
A Technical Forum featuring representatives from Dow Chemical, ISP, and DMV-Fonterra Excipients. This article is part of PharmTech's supplement "Solid Dosage and Excipients 2010." This article is part ...
CD Formulation has recently introduced liposome formulations, which are remarkably better at absorption, stability, and release. NY, UNITED STATES, December 13, 2024 ...
The global formulation development outsourcing market is on a significant growth trajectory, with a projected compound annual growth rate (CAGR) of 7.2% over the next decade. Valued at USD 33.23 ...
The aim of any formulation scientist is to create a product that is safe, effective, stable, and distinct from competitor drugs. It also helps if the product is as patient friendly as possible to ...
The global formulation development outsourcing industry was estimated at $22.5 billion in 2021, and is anticipated to hit $51.9 billion by 2031, registering a CAGR of 9% from 2022 to 2031. The ...
This unique 3 day course is designed to integrate the key elements of tablet development with hands-on, practical experience in a small scale, lab scale test facility. Each day will consist of ...
There has been recent progress on the development of pediatric drug formulations, but further development of better medicines for children should focus on a certain set of priorities, according to a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback